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Abstract 
Microgravity of spaceflight induces bone loss due in part to decreased bone formation by 
osteoblasts.  We have previously examined the microgravity-induced changes in gene expression 
profiles in 2T3 preosteoblasts using the Random Positioning Machine (RPM) to simulate 
microgravity conditions.  Here, we hypothesized that exposure of preosteoblasts to an 
independent microgravity simulator, the Rotating Wall Vessel (RWV), induces similar changes 
in differentiation and gene transcript profiles, resulting in a more confined list of gravi-sensitive 
genes that may play a role in bone formation.  In comparison to static 1g controls, exposure of 
2T3 cells to RWV for 3 days inhibited alkaline phosphatase activity, a marker of differentiation, 
and downregulated 61 genes and upregulated 45 genes by more than two-fold as shown by 
microarray analysis.  The microarray results were confirmed with real time PCR for 
downregulated genes osteomodulin, bone morphogenic protein 4 (BMP4), runx2, and 
parathyroid hormone receptor 1.   Western blot analysis validated the expression of three 
downregulated genes, BMP4, peroxiredoxin IV, and osteoglycin, and one upregulated gene 
peroxiredoxin I. Comparison of the microarrays from the RPM and the RWV studies identified 
14 gravi-sensitive genes that changed in the same direction in both systems.  Further comparison 
of our results to a published database showing gene transcript profiles of mechanically loaded 
mouse tibiae revealed 16 genes upregulated by the loading that were shown to be downregulated 
by RWV and RPM.  These mechanosensitive genes identified by the comparative studies may 
provide novel insights into understanding the mechanisms regulating bone formation and 
potential targets of countermeasure against decreased bone formation both in astronauts and in 
general patients with musculoskeletal disorders.      
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Introduction 
Exposure to microgravity conditions during spaceflights induces several adaptive and 
pathophysiological changes to the human body, posing health risks to astronauts during space 
flights.  These pathophysiological changes include reduced cardiovascular performance (1, 2), 
immune system dysfunction (3), skeletal muscle atrophy (4, 5), bone demineralization (6-9), 
decreased bone mass (10-13), and increased bone resorption (13, 14).  Astronauts lose bone mass 
as much as 1%-2% per month during spaceflight, and this may be due to either  decreasing bone 
formation by osteoblasts or increasing osteolytic functions of osteoclasts (6, 14).  Many of the 
known space-inflicted pathologies have been the subject of research, and the bone loss has not 
been adequately counteracted with dietary supplements (12, 15, 16) or rigorous exercise (4).  
This is due in part to the lack of understanding of the mechanisms leading to the effects of 
microgravity on bone cells.    
While it would be ideal to conduct studies to discover the mechanisms in real 
microgravity conditions, it has become extremely difficult, rare, expensive, and impractical to 
most investigators.  As an alternative, and a complementary means in some cases, investigators 
have developed ground-based systems to simulate microgravity conditions on Earth (17-20).  
Simulated microgravity is based on the hypothesis that sensing no weight would have similar 
effects as being weightless (21).  The 1D and 3D clinostats such as the Rotating Wall Vessel 
bioreactor (RWV) and the Random Positioning Machine (RPM) simulate microgravity by 
continuously moving the gravity vector, a method called gravity-vector averaging, yielding a net-
zero sum of gravity vectors averaged over time.  The key aspect in gravity-vector averaging is 
that the movement of the gravity vector must be faster than the cell sensors can detect gravity 
(19).    
For the microgravity simulators to be used widely and accepted as valid model systems to 
study microgravity effects on human biology, the biological and pathophysiolocial effects of 
each simulator should be compared to each other and, if possible, to real microgravity 
conditions.  There is one comparison between the RPM and the RWV in which cell proliferation 
and cytoskeletal organization were evaluated in endothelial cells exposed to both simulators (22).  
However, detailed experiments assessing biological function and genetic changes were not 
performed, and there was no discussion relating the observed changes to microgravity-induced 
pathologies.  However, as far as we are aware, no unbiased comparison amongst the various 
microgravity simulators as related to bone loss studies has been reported.   
Recently, we have characterized gene transcript expression profiles of 10,000 genes using 
Codelink gene chips in 2T3 murine pre-osteoblasts exposed to RPM-simulated microgravity 
conditions (20).  We compiled a list of 140 genes (gravi-sensitive genes) that changed in 
response to the simulated microgravity conditions with the RPM, and some of them may be 
involved in decreased bone formation.  In contrast, Xing et al, have characterized gene transcript 
profile changes induced by exposing mouse tibia to mechanical stimulation, an apparent opposite 
of microgravity conditions, using a four-point bending method (23).  Therefore, we hypothesized 
that simulated microgravity using the RWV inhibits differentiation and alters gene expression 
profiles of 2T3 pre-osteoblasts, recapitulating the trends produced by the RPM, while inducing 
the opposite trends produced by mechanical stimulation of bones.  To test this hypothesis, we 
carried out an additional gene transcript profiling study with 2T3 cells exposed to the NASA 
developed RWV, and compared the results to our previous transcript database obtained with the 
RPM.  In addition, we compared both the RWV and RPM transcript databases to the database 
obtained from the mechanically loaded mouse tibias (23).  From these studies, we found 16 
genes that were affected in all three studies, suggesting that they may be implicated in 
microgravity-induced decrease in bone formation.   
 
Results 
RWV-simulated microgravity inhibits alkaline phosphatase activity. 
Expression of alkaline phosphatase (ALP) increases as osteoblasts mature and 
differentiate, and its enzyme activity is often used as a marker for bone formation.  Thus, we 
chose to examine the effects of RWV-simulated microgravity on ALP enzyme activity in pre-
osteoblasts.  As shown in Figure 2, exposure of cells to the RWV for 3 days significantly 
decreased ALP mRNA (Panel A) and its activity (Panel B) by 3-fold in comparison to static 1g 
controls.  This finding, which is consistent to our previously reported data with the RPM (20), 
suggests that the simulated microgravity conditions induced by either the RWV or the RPM 
results in the similar inhibitory effect on osteoblast differentiation.   
 
RWV-simulated microgravity alters gene expression profiles of 2T3 cells as determined by 
microarray studies.     
DNA microarray studies were performed on samples obtained from 2T3 cells exposed to 
the static 1g or RWV-simulated microgravity for 3 days.  Among approximately 40,000 genes 
tested by the Affymetrix array, 61 were downregulated while 43 were upregulated statistically 
significantly by more than two fold above the static 1g control (p<0.05) as shown in a scatter plot 
of the genes (Figure 3).  Table 1 shows a subset of these genes organized by biological process 
as defined by GoMiner, and each gene is given an associated molecular function where available.  
Additionally, Table 2 provides a list of genes from the microarray that may be implicated in bone 
formation or mineralization as determined by literature survey, and these genes are organized by 
fold change with molecular function when known.  The entire array can be accessed from Gene 
Expression Omnibus (GEO). 
 
Validation of the microarray data with the quantitative Real Time-PCR and 
immunoblotting. 
To confirm our microarray data, we performed real time PCR and Western blot analyses 
for a select subset of genes that may be implicated in bone formation.  The same samples that 
were used for the microarrays were used for the real time-PCR, and additional RWV 
experiments were performed to obtain protein samples for the Western blots.  The 2T3 cells 
exposed to RWV had decreases in runt related transcription factor 2 (Runx2), bone morphogenic 
protein 4 (BMP4), parathyroid hormone receptor 1 (PthR1), and osteomodulin (Omd) gene 
expression by a fold change of 0.69, 0.40, 0.54, and 0.10, respectively, as evaluated by the 
Affymetrix microarray.  The gene expression fold changes by real time PCR for Runx2, BMP4, 
PthR1, and Omd, were 0.38, 0.26, 0.59, and 0.10, respectively (Figure 4 A-E).  Additionally, we 
confirmed the expression of downregulated genes BMP4, peroxiredoxin IV (PrxIV), and 
osteoglycin (Ogn) and upregulated gene peroxiredoxin I (PrxI) by immunoblotting.  The 
Affymetrix fold changes for BMP4, PrxIV, Ogn, and PrxI were 0.40, 0.62, 0.23, and 1.23.  We 
showed that the fold changes for these genes by Western blot were 0.59, 0.68, 0.32, and 1.58, 
respectively (Figure 4 F-J).  The different methodologies used, real time PCR, immunoblotting, 
and the microarray assay, produced highly consistent results, providing a level of assurance 
regarding the validity of the microarray data.     
 
Comparison of the RPM and RWV microarrays reveals 14 genes that changed in the same 
way. 
There was a subset of genes that demonstrated similar expression changes when exposed 
to simulated microgravity in both the RPM and RWV experiments.  Table 3 displays those genes 
that changed statistically significantly with p<0.05.  There were 13 downregulated genes and 1 
upregulated gene in this group.  With such a small sample size (n=3), we felt it was valuable to 
evaluate which genes changed commonly in both simulators with less stringent p-value cutoffs.  
Under this non-stringent condition, there were also 11 downregulated and 5 upregulated genes 
whose change in expression did not reach statistical significance (0.05<p<0.1) but changed in the 
same direction with exposure to both simulators (data not shown).  Table 3 organizes the 
significant genes by biological process as defined by GoMiner and associates each gene with a 
molecular function, if known.  Interestingly, many of the genes in both tables have been 
implicated in skeletal remodeling, including fibromodulin, osteomodulin, and osteoglycin (24-
26).   
 
Comparison of microgravity microarrays to a mechanical loading microarray produced a 
list of 16 genes that changed in opposite directions between microgravity and mechanical 
loading. 
Recently, Xing, et al. published their microarray data on mice that were mechanically 
loaded (23).  Briefly, they loaded mice in a four point bending mechanical device for four days 
and total RNA was obtained from the region of the mechanically stimulated tibia.  The untreatd 
tibias of the same mice were used as unloaded controls.  They used a 22,000 gene Agilent 
Technologies microarray (23).  We compared our RPM and RWV microarrays to their published 
data and compiled an interesting list of common genes changing in opposite directions.  Sixteen 
genes that were upregulated by loading were downregulated in the cells exposed to simulated 
microgravity conditions by the RPM and RWV (Table 4).   Table 4 compares the fold changes 
for the RWV, RPM, and mechanically-loaded mouse tibias.  There were many genes that were 
altered by loading and microgravity that are believed to play roles in bone remodeling, including 
pleiotrophin, legumain, and follistatin (27-31).   
 
Discussion
We have previously developed an in vitro method combining the 3D-clinostat RPM and 
2T3 pre-osteoblasts cells cultured in tissue culture disks called Opticells, in which the cells are 
encapsulated by two polystyrene, gas-permeable membranes to which the cells are adhered (20).  
The RPM-simulated microgravity significantly inhibited alkaline phosphatase activity over a 
time course of 9 days, without significantly altering cell morphology or cell proliferation (20).  
Additionally, using gene microarrays scanning 10,000 mouse genes, we produced a list of 52 
upregulated and 88 downregulated genes by more than two-fold above the static 1g control with 
statistical significance (p<0.05).   
Here, we used another approach to expose the adherent 2T3 cells to simulated 
microgravity using the 1-D clinostat RWV bioreactor, which maintains constant suspension of 
the cells.  Unlike the RPM system where the cells were attached to OptiCell membranes and 
exposed to simulated microgravity, the RWV does not have a similar platform so the adherent 
cells had to be grown on microcarriers for exposure to RWV-simulated microgravity.  To 
compare the results of the RWV to those published with the RPM, we aimed to control the 
experimental conditions as much as possible.  We used the same seeding density of 10,000 
cells/cm , and we chose a microcarrier that had the most similarity to the Opticell membrane, 
which was used in the RPM studies.  In our previous RPM studies, 2T3 cells grew well on the 
OptiCells without requiring any extracellular matrix other than what was available from fetal 
bovine serum contained in the cell culture medium.  Therefore, we used the same culture 
conditions to grow 2T3 cells on the microcarriers and found no difference in cell growth and 
morphological characteristics (data not shown). Under this condition, we found that cells adhered 
to the microcarriers with 80% efficiency (n=9) within a day as determined by cell counting.  
Most importantly, we independently confirmed the RPM data showing that the RWV produced 
similar results regarding cell differentiation, as determined by alkaline phosphatase (ALP) 
enzyme activity.   These results suggest that the RPM and RWV exposures inhibit cell 
differentiation of pre-osteoblasts, a finding that seems to be consistent with the microgravity-
induced bone loss response.  
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Previously, it has been controversial whether RWV-simulated microgravity decreases or 
increases ALP activity, but this may be due to a difference of whether the cells were grown as 
attached vs. suspended cells.  Rucci, et. al. found that ALP activity and mRNA expression 
increased when exposed to the RWV for 2 days using the rat osteoblast-like cell line that was 
grown as a suspension, which then formed aggregates (32).  In contrast, Klement, et al. showed 
that exposure to the RWV for up to 14 days blunted ALP activity and bone matrix mineralization 
of mouse embryonic pre-metatarsal tissue explants(18).   It should be noted that in this condition 
the bone cells were still attached on the extracellular matrix within the embryonic bone tissues.  
In our current and the previous study, the pre-osteoblasts were grown as adherent cells either on 
microcarriers or on the OptiCell membranes before and during exposure to the RPM or RWV.  
These results suggest that the inhibitory effect of the RWV and RPM on the osteoblastic function 
requires the bone cells grown as adherent cells during the exposure to the simulated 
microgravity.  Additionally, our finding partially validates and supports the use of ground-based 
simulators to study microgravity-induced changes in bone cell biology and pathophysiology. 
We also performed gene microarray analysis to determine changes in gene expression 
profiles of the pre-osteoblasts and compared the results to our published findings with the RPM.  
We found that 14 genes changed in the same way, and many of these genes are involved in 
skeletal remodeling.  For example, we confirmed expression levels of runx2, which was 
downregulated by approximately 1.5-fold and is believed to be a “master gene” that plays a 
critical role in the formation of the skeleton.  When Runx2 is genetically knocked out in a mouse 
model, there is a complete lack of skeleton formation (33, 34).  Additionally, asporin (Aspn) and 
proline arginine-rich end leucine-rich repeat protein (PRELP) were both downregulated by 
simulated microgravity in both the RWV and RPM by 3.5 and 2.2-fold, respectively.  Asporin is 
a cartilage extracellular protein and a member of the well known family of secreted 
proteoglycans present in many connective tissues called small leucine rich proteoglycans 
(SLRPs) (35, 36).   Aspn is known to regulate the activity of transforming growth factor-beta 
(TGFβ) and forms an association with calmodulin 1 (Calm1), which is an intracellular protein 
that interacts with a number of proteins involved in signal transduction.  The association of Aspn 
and Calm1 reduces the ability of chondrocytes to make aggrecan and type II collagen (35).  
Aggrecan and type II collagen are essential constituents of articular cartilage, and collagen 
abnormalities are associated with skeletal abnormalities (35).  PRELP is categorized by GoMiner 
to be involved in skeletal development and has been found to bind collagen type I and type II 
through its leucine-rich repeat domain (37).  A decrease in parathyroid hormone related protein, 
which plays a role in calcium mobilization, has been linked to decreases in bone density and 
subsequent bone loss in space-flown rats (38).  This is consistent with the decrease in the 
parathyroid hormone receptor 1 levels by simulated microgravity, which was confirmed by RT-
PCR.  Osteomodulin belongs to the SLRP family and may be involved in bone matrix formation 
(25), and simulated microgravity-induced decrease in Omd is consistent with our hypothesis.   
Additionally, we confirmed the downregulated expression levels of bone morphogenic 
protein 4 (BMP4), a member of the bone morphogenic protein (BMP) family, and BMP4 is 
involved in skeleton development, including cartilage formation and various joint developments 
(39, 40).   Moreover, oxidative stress is involved in the etiology of various pathologies, and 
oxidants are produced under physiological conditions during phagocytosis by macrophages, 
mitochondrial electron transport, and bone resorption by osteoclasts (41).   Bone resorption is 
known to increase beyond normal physiological levels in spaceflight (14), potentially increasing 
the levels of oxidative stress in the human body.  Oxidative stress can lead to breaks in DNA, 
depletion of cellular energy stores, and cell death, and oxidants play important roles in cell 
signaling (41).  Peroxiredoxins are a family of antioxidants that are often made by cells in 
response to oxidant production.  It has been found that peroxiredoxin I is upregulated during 
bone cell differentiation (41, 42).  We found that PrxI was upregulated while peroxiredoxin IV 
was downregulated by RWV-simulated microgravity, suggesting that the cells may be 
responding to oxidative stress agents and trying to compensate for these changes.  Moreover, 
from Table 1, there is a large group of genes involved in cell adhesion that changes upon 
exposure to simulated microgravity.  In general, with the exception of procollagen XI, several of 
these genes that were upregulated are extracellular matrix proteins such as procollagen IV and 
integrin alpha 6.  There also were several genes involved in cytoskeletal regulation that changed, 
such as tubulin.   It also seems that heat shock proteins involved in protein folding change upon 
exposure to simulated microgravity.  These results indicate possible candidate genes involved in 
decreased bone formation in astronauts, suggesting that this decrease is related to changes in the 
expression of genes necessary for osteoblast differentiation, matrix formation, subsequent 
mineralization, and cartilage maintenance.   
 To further investigate the functional significance of the microgravity-associated changes 
in gene expression, we compared our microarray results to independently published data from 
mechanically loaded tibias in a mouse model (23).  When we compared their gene chip results to 
those of the RPM and RWV microarrays, we found 16 genes that were upregulated by 
mechanical loading and contrastingly dowregulated by simulated microgravity.  Moreover, many 
of these genes are highly involved in bone remodeling.  For example, pleiotrophin and 
osteoglycin were not only downregulated by simulated microgravity but also upregulated by 
mechanical loading.  Pleiotrophin has been found to be involved in early bone development and 
osteoblast function (27).  Overexpression of pleiotrophin in mice enhances bone growth early in 
development, but its effects diminish over time (27).   However, the pleiotrophin knockout 
mouse does not have an altered bone remodeling phenotype (28).  Pleiotrophin is synthesized by 
osteoblasts at an early stage of differentiation, and the gene is present at new sites of bone 
formation (29).  Osteoglycin is a small leucine-rich proteoglycan found in the extracellular 
matrix of bone, and knockout mice for this gene display collagen fibril diameter abnormalities 
(24).  Additionally, legumain has been identified as an inhibitor of osteoclast function and thus 
bone resorption (30).  Simulated microgravity by the RPM and RWV downregulated this 
inhibitor with fold changes of 0.66 and 0.64, respectively, while loading upregulated legumain 
by 3.3-fold, suggesting that microgravity may induce expression of genes normally involved in 
bone resorption.  Disruption of the tight coupling between bone formation and bone resorption 
has been recognized as a general mechanism inducing bone loss (43, 44).  Microgravity-induced 
alteration of genes like legumain is consistent with this notion.  These comparisons suggest that a 
subset of these gravity-sensitive genes is also mechanical load-sensitive and may be implicated 
in microgravity-induced decreased bone formation.  Spaceflight is characterized as an 
environment in which the human body is no longer loaded as on Earth.  Therefore, it is 
interesting that many genes that are changed by loading are also changed in the opposite 
direction by “unloading”, or simulated microgravity.   
In conclusion, we have shown that the two different simulators of microgravity produce 
similar results with regard to bone cell differentiation and osteoblast function.  We have shown 
by alkaline phosphatase activity that both simulators reproduce a decreased bone formation 
response as also seen in spaceflight.  Furthermore, we have compiled a confined list of genes that 
change in response to the two different types of simulated microgravity conditions and to 
mechanical loading, which could provide a limited number of specific targets for interventions to 
cure or prevent bone loss not only in astronauts but also in patients on Earth with various 
metabolic musculoskeletal diseases.   
 
Materials and Methods 
Cell culture—2T3 murine osteoblast precursor cells were cultured in MEM [ -minimal essential 
medium containing 10% fetal bovine serum (Atlanta Biologicals) with 100 U/ml penicillin and 
100 µg/ml streptomycin] in a standard humidified incubator (37°C, 5% CO2) as described by us 
previously (20).  For RWV experiments, trypsinized cells were seeded on microcarriers (#P102-
1521, Solohill, Ann Arbor, MI), which has a polystyrene core with no extracellular matrix 
coating.  Microbeads, needed to obtain 100cm2 surface growth area based on the surface area of 
each bead, were prepared in sterile PBS (50mg/ml) and autoclaved as suggested by the 
manufacturer.  We plated 1 million cells with 5.6 grams of beads in a low adhesion 100mm plate 
(Corning, Inc. #3262) so that the cells adhered to the beads and not the plate.  The cells were 
allowed to grow for 3 days to confluency and then transferred to a RWV with approximately 
55ml of culture media.  Media bubbles were removed with a two-syringe system.  For static 1g 
control, cells were kept in the same incubator in the low adhesion plate with the identical media 
for the matching experimental duration as the RWV group. 
 
Rotating Wall Vessel (RWV )– Rotation of the RWV (Figure 1) maintains microbeads attached 
with 2T3 pre-osteoblasts in a continuous free-fall state, simulating a microgravity environment 
(45).  The RWV is rotated in a single mode, and the rate of rotation varies according to cell type, 
microcarrier density, and number of cell-bead aggregates.  For our experiments, we rotated the 
RWV at 22 RPMs (rotations/minute).  Over three days of RWV exposure, the rotation rate did 
not need to be altered as the cell-bead aggregates maintained suspension.  Figure 1-B shows the 
RPM (20) as a comparison.   
 
Whole cell lysate and alkaline phosphatase enzyme activity—Following the RWV or static 1g 
exposure, cells and beads were washed with cold PBS 2 times and lysed in 500 µl of a lysis 
buffer containing 0.1% Triton X-100 in 1mM MgCl2, 20mM Tris-HCl, and 0.1mM ZnCl2.  The 
lysate and bead mixture was centrifuged for 3-5 minutes at 1,500 rpm to separate the beads from 
the lysate.  The lysate was pipetted out of the mixture and stored at –20°C until needed.  Protein 
assay using the Bio-Rad DC protein assay and the alkaline phosphatase activity using a 
Diagnostics ALP assay kit (Sigma) were carried out as we described previously (20).   
 Immunoblotting—Aliquots of cell lysates (20 µg protein) were resolved on a SDS-PAGE gel and 
transferred to a polyvinylidene difluoride membrane (Millipore) (46).  The membrane was 
incubated with a primary antibody overnight at 4°C and then incubated with a secondary 
antibody conjugated with alkaline phosphatase for 1 h at room temperature.  Expression was 
detected by a chemiluminescence method and the intensities of immunoreactive bands were 
determined by densitometry (46).  A polyclonal primary antibody for BMP4 (Santa Cruz 
Biotechnologies), osteoglycin (R&D Biosciences), and polyclonal antibodies for peroxiredoxin I 
and peroxiredoxin IV (Lab Frontier, Seoul, Korea) were used for these studies. 
 
RNA isolation—Total RNA was prepared by using the RNeasy Mini kit (Qiagen).  Briefly, after 
two cold PBS washes, 500ul of RLT lysis buffer containing β-mercaptoethanol was added to the 
bead and cell mixture to isolate the RNA from the beads and cells.  The bead and lysate mixture 
was centrifuged for 3 minutes at 1,500 RPMs to separate the beads from the RNA, and the RNA 
was pipetted to the homogenizing column in the RNeasy kit.  The RNA was purified with the kit 
and stored at –80°C until needed.   
 
Reverse Transcriptase and Real-Time Polymerase Chain Reaction— Total RNA was reverse 
transcribed by using random primers and a Superscript-II kit (Life Technology) (47).  The 
synthesized and purified cDNA was amplified using a LightCycler (Roche Applied Science), and 
the size of each PCR product was verified by agarose gel electrophoresis as described by us (47).  
The mRNA copy numbers were determined based on standard curves generated with the genes 
of interest and 18S templates. The 18S primers (50 nM at 61ºC annealing temperature; Ambion) 
were used as an internal control for real-time PCR using capillaries (Roche Applied Science), 
recombinant Taq polymerase (Invitrogen), and Taq start antibody (Clontech).  The primer pairs 
for the quantitative real-time PCR are listed in Table 5 along with Light Cycler conditions.  Real-
time PCR for the listed genes were carried out in PCR buffer (20mM Tris-Cl, pH 8.4 at 25°C, 
4mM MgCl2, 250 µg/ml bovine serum albumin, and 200 µM deoxynucleotides) containing 
SYBR green (1:84,000 dilution), 0.05unit/µl Taq DNA polymerase, and Taq Start antibody 
(1:100 dilution) as described previously by us (47).   
 
Affymetrix Gene Microarrays— All RNA samples passed the microarray test for RNA quality 
and concentration before proceeding to the gene chip study carried out in the Microarray Core 
Facility at the Baylor College of Medicine.  The array used was Affymetrix GeneChip® Mouse 
430 2.0, and the data were background adjusted and normalized to median intensity.  The data 
were transformed so that fold changes were obtained by dividing the averaged normalized 
intensities of the microgravity samples by the averaged normalized intensities of the static 
samples.  Thus, a fold change above 1 indicates a gene upregulated by simulated microgravity 
and below 1 indicates a gene downregulated by simulated microgravity.   The data were 
statistically analyzed by DNA chip analyzer (dChip) as described below in Statistical analysis 
section and filtered for fold change threshold, and the genes that changed in response to 
simulated microgravity by more than 2-fold above or below the static 1g controls with p-values 
of less than 0.05 were deemed considerable and statistically significant.  The number of 
differentially expressed genes and false discovery rate (FDR) were calculated for each of 500 
permutations, and 1,934 genes had p-values less than 0.05 at median FDR. Roughly, half of these 
genes were false positives.  GoMiner software (http://www.miblab.gatech.edu/gominer) was 
used to sort the genes by biological processes and to assign some of the known functions of each 
known gene (48).   
 
Statistical analysis—Statistical analysis was performed using the Student's t-test for ALP enzyme 
activity experiments. A significance level of p<0.05 was considered statistically significant.  The 
microarray data was analyzed with the dChip, a program based on the Model-Based Expression 
Index (MBEI) method (49, 50).  The raw data were normalized using the invariant set 
normalization, and the average expression values are represented as model-based expression 
indices. We used the ‘PM only model’, and the expression values were expressed in log2 scale. 
Differential gene expression between two groups of samples was analyzed by t-test built in 
dChip.  
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Figure Legend 
 
Figure 1.  RWV exposure inhibits alkaline phosphatase activity and mRNA expression in 
2T3 cells.  Confluent 2T3 cells grown on microcarriers were placed in the RWV for 3 days of 
rotation or incubated in T-75 flasks for static 1g controls for the same period.  The alkaline 
phosphatase activity (A) was determined by a colorimetric assay using cell lysates and alkaline 
phosphatase (ALP) mRNA levels (B) determined by real time PCR with 18S as an internal 
control.  The graphs show mean ± SEM (* p<0.05, n=6 for A and n=3 for B).   
 
Figure 2.  The effects of RWV-simulated microgravity on gene transcript profiles of 2T3 
cells as determined by Affymetrix microarray analysis.  Total RNA was isolated from 2T3 
cells exposed to RWV or static 1g controls for 3 days. cRNA was then prepared and analyzed by 
Affymetrix microarrays corresponding to 40,000 mouse genes.  The scatter plot shows mean 
intensities of each gene probe using the data obtained from all microarrays.  Statistical analysis 
identified 66 genes upregulated (red dots) and 45 genes downregulated (green dots) by more than 
2-fold compared to static 1g control (p<0.05, n=3).  Unchanged genes are shown in black in the 
scatter plot.   
 
Figure 3.  Verification of microarray results by real time PCR and Western blot for genes 
that were upregulated or downregulated by RWV exposure of 2T3 cells. Aliquots of total 
RNA used for microarray studies (n=3, simulated µg and static 1g) were used for the quantitative 
real time PCR assay for Runx2 (A), BMP4 (B), PthR1 (C) and osteomodulin (OMD, D) using 
18S rRNA as internal controls.  Additional experiments were performed to obtain cell lysates for 
the Western blot assay using antibodies specific to BMP4 (F), peroxiredoxin IV (Prx IV, G), 
osteoglycin (Ogn, H), and Prx I (I) using β-actin as an internal control.   Error bars shown 
represent mean ± SEM (n≥3, * p< 0.05). Comparison of the Affymetrix microarray fold changes 
to the quantitative RT-PCR (E) or Western blot results (J).  
 
Figure 4.  Simulated microgravity using the RWV and the RPM.  A. The Rotating Wall 
Vessel (RWV) bioreactor is a one-dimensional clinostat that simulates microgravity conditions 
by maintaining particles in a free-fall state.  B. The Random Positioning Machine (RPM) is a 
three-dimensional clinostat that simulates microgravity by continuously rotating the cells in a 
random orientation at random speeds.  Both simulators use the gravity vector averaging method 
to simulate microgravity. 
 Table 1 A list of selected statistically significant genes sensitive to RWV simulated microgravity in 2T3 cells. Sorted based on 
typical biological process (p<0.05).   
Accession # Gene Name *Fold Δ p-value Molecular Function 
Cell Adhesion     
NM_012050 osteomodulin 0.10 0.04 aka osteoadherin, may mediate cell attachment 
NM_011581 thrombospondin 2 0.39 0.03 structural molecule activity; calcium ion binding 
BB781435 nidogen 2 0.39 0.004 calcium ion binding 
NM_007729 procollagen, type XI, alpha 1 0.40 0.04 extracellular matrix structural constituent 
NM_012043 immunoglobulin superfamily containing leucine rich repeat  (ISLR) 0.42 0.02 involved in cell attachment 
BB250384 
L08431 vascular cell adhesion molecule 1 0.45 0.02 protein binding 
BF225985 discoidin domain receptor family, member 1 0.49 0.04 protein kinase activity; protein serine/threonine kinase activity 
BC013560 procollagen, type IV, alpha 2 2.02 0.03 structural molecule activity; extracellular matrix structural constituent 
BG073728 RGM domain family, member B 2.24 0.05 protein self binding 
BM935811 integrin alpha 6 2.47 0.01 receptor activity; protein binding 
BF158638 procollagen, type IV, alpha 1 2.59 0.002 structural molecule activity; extracellular matrix structural constituent 
Cell Cycle     
NM_011817 
AK007410 growth arrest and DNA damage inducible, gamma 0.40 0.009 structural constituent of ribosome 
AK004608 heat shock protein 8 2.27 0.04 protein binding; ATP binding 
Cell 
Differentiation     
NM_025711 asporin 0.15 0.05 porin activity; cartilage extracellular protein 
Development     
NM_031258 chordin-like 1 0.16 0.03 unknown 
NM_009144 secreted frizzled-related sequence protein 2 0.43 0.03 transmembrane receptor and signal transduction activity 
BB549310 olfactomedin 1 2.66 0.02 unknown 
Skeletal 
Development     
NM_007554 bone morphogenetic protein 4 0.40 0.002 cytokine activity 
NM_054077 proline arginine-rich end leucine-rich repeat 0.43 0.05 extracellular matrix structural constituent 
NM_011641 transformation related protein 63 0.47 0.04 DNA binding; transcription factor activity 
Cell Growth     
NM_010516 cysteine rich protein 61 0.24 0.02 protein binding; insulin-like growth factor binding 
 
 
Accession # Gene Name *Fold Δ p-value Molecular Function 
NM_016873 WNT1 inducible signaling pathway protein 2 0.39 0.01 phospholipase A2 activity; calcium ion binding 
BC020038 endothelial cell-specific molecule 1 0.46 0.01 insulin-like growth factor binding 
Cytoskeletal 
Regulation     
NM_008857 protein kinase C, iota 0.45 0.04 actin filament organization 
AV297945 myosin X 0.46 0.046 motor activity; actin binding 
AW491660 tubulin, alpha 4 2.42 0.007 microtubule based movement; GTPase activity; structural molecule activity 
Metabolism     
NM_007934 glutamyl aminopeptidase 0.40 0.03 DNA binding; protein binding 
AY057913 brain derived neurotrophic factor 0.46 0.02 mechanoreceptor differentiation; protein binding; growth factor activity 
NM_007436 aldehyde dehydrogenase family 3, subfamily A1 2.56 0.04 aldehyde dehydrogenase activity 
Proteolysis     
NM_011269 Rhesus blood group-associated A glycoprotein 0.36 0.01 cysteine-type endopeptidase activity 
AF282844 matrix metalloproteinase 16 0.47 0.04 metalloendopeptidase activity 
BB658835 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) 0.48 0.03 metalloendopeptidase activity; peptidase activity 
AK011596 transferrin receptor 2.40 0.05 receptor activity; transferrin receptor activity 
Signal 
Transduction     
NM_008046 follistatin 0.39 0.02 BMP signaling pathway 
Protein Folding     
NM_013560 heat shock protein 1 2.03 0.04 unknown 
NM_011020 heat shock 70kDa protein 4 like 2.06 0.02 ATP binding; unfolded protein binding 
Transport     
AK018504 ras association (RalGDS/AF-6) domain family 2 0.43 0.27 protein binding 
AV344473 sorting nexin associated golgi protein 1 0.48 0.008 unknown 
BB280137 RAB guanine nucleotide exchange factor (GEF) 1 0.48 0.02 DNA binding; zinc ion binding 
BB144704 ATP-binding cassette, sub-family A (ABC1), member 1 0.48 0.02 ATP binding; ATPase activity 
Chromosome 
Organization     
BB533903 histone 1, H1c 0.29 0.03 DNA binding; protein binding 
M25487  
NM_023422 histone 1, H2bc 0.44 0.03 DNA binding 
 
 
Accession # Gene Name *Fold Δ p-value Molecular Function 
Nitric  Oxide 
Synthesis     
BF166000 high mobility group box 1 0.41 0.04 nitric-oxide synthase regulator activity 
Multidrug 
Transport     
BB291885 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 2.35 0.003 multidrug efflux pump activity 
Endocytosis     
AI848122 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor 2.30 0.04 receptor activity; calcium ion binding 
Stress or Immune 
Response     
NM_007705 cold inducible RNA binding protein 0.21 0.003  
D67017 heat shock protein 105 2.54 0.02 protein binding; ATP binding 
AW763765 heat shock protein 1A 3.18 0.04 ATP binding 
Regulation of Cell 
Growth     
NM_008760 osteoglycin 0.23 0.03 growth factor activity 
Negative 
Regulation of Cell 
Growth 
    
NM_009517 wild-type p53-induced gene 1 2.18 0.03 unknown 
Unknown      
BC002065 serine (or cysteine) proteinase inhibitor, clade A, member 3G 0.35 0.02 endopeptidase inhibitor activity 
NM_133859 olfactomedin-like 3 0.40 0.02 unknown 
NM_016753 latexin 0.44 0.01 enzyme inhibitor activity; metalloendopeptidase inhibitor activity 
NM_007984 fascin homolog 1, actin bundling protein 0.47 0.04 actin binding; actin filament binding 
NM_029632 protein phosphatase 1, regulatory (inhibitor) subunit 11 2.17 0.03 unknown 
AI266910 ceroid-lipofuscinosis, neuronal 2 2.07 0.04 serine-type endopeptidase activity 
NM_009266 selenophosphate synthetase 2 2.02 0.004 catalytic activity 
* Fold=simulated microgravity expression/static 1g expression
 Table 2 The effect of microgravity on selected genes that may be involved in osteoblast differentiation and matrix 
mineralization. Sorted based on fold changes.   
Accession # Gene Name *Fold Δ p-value Molecular Function 
NM_012050 osteomodulin 0.10 <0.05 aka osteoadherin, may mediate cell attachment 
NM_008760 osteoglycin 0.23 <0.05 binds to TGF-beta, no GAG in bone, keratan sulfate in other tissues 
NM_025711 asporin 0.28 <0.05 porin activity; cartilage extracellular protein 
BG229308 procollagen, type VIII, alpha 2 0.35 >0.1 present in cartilage 
BC002065 serine (or cysteine) proteinase inhibitor, clade A, member 3G 0.35 <0.05 may be involved in osteoclast function with MMPs and cathepsins 
NM_007729 procollagen, type XI, alpha 1 0.37 <0.05 present in cartilage 
NM_011581 thrombospondin 2 0.39 <0.025 involved in cell attachment 
NM_016873 WNT1 inducible signaling pathway protein 2 0.39 <0.05 involved in WNT pathway, WNT stimulated by BMPs 
BB781435 nidogen 2 0.39 <0.005 calcium binding 
NM_007554 bone morphogenetic protein 4 0.40 <0.0025 growth factor and cytokine activity 
BM218630 protocadherin 18 0.40 >0.05 calcium ion binding 
NM_011693 vascular cell adhesion molecule 1 0.41 <0.025 cell adhesion molecule activity 
BB396904 calmodulin 3 0.41 >0.1 calcium binding; regulates osteoclast differentiation 
NM_012043 immunoglobulin superfamily containing leucine rich repeat  (ISLR) 0.42 <0.05 involved in cell attachment 
NM_009144 secreted frizzled-related sequence protein 2 0.43 <0.05 WNT signaling pathway antagonist 
BC002064 pleiotrophin 0.43 >0.1 involved in bone mineralization 
NM_009821 runt related transcription factor 1 0.43 >0.1 mesenchymal cell differentiation 
BI111620 tissue inhibitor of metalloproteinase 3 0.44 >0.1 may be involved in bone resorption 
NM_021355 fibromodulin 0.45 >0.05 binds to collagen, may regulate fibril formation, binds to TGF-beta 
BB431535 matrix metalloproteinase 16 0.47 <0.05 involved in osteoclast function and bone resorption 
M93954 tissue inhibitor of metalloproteinase 2 0.48 >0.1 involved in bone resorption 
AW412729 procollagen, type XII, alpha 1 0.48 >0.05 present in collagen; extracellular matrix structural constituent 
C76813 a disintegrin and metalloproteinase domain 17 0.48 >0.1 involved in matrix protein degradation; prevent osteoclast recruitment 
BB371406 frizzled homolog 2 (Drosophila) 0.48 >0.1 involved in WNT pathway 
NM_009933 procollagen, type VI, alpha 1 0.49 <0.1 present in cartilage 
AU021035 syndecan 2 0.50 >0.1 binds to type 1 collagen, fibronectin, tenascin-C 
AA717838 interleukin 6 signal transducer 0.50 >0.1 act as stimulators of an early stage of osteoclast formation 
BF580235 cathepsin E 0.50 >0.1 involved in bone resorption 
NM_010511 interferon gamma receptor 1 0.52 >0.05 inhibit bone resorption 
BE628614 annexin A4 0.52 >0.1 expressed in osteoblasts and relocation dependent on calcium 
BF537076 interferon gamma receptor 2 0.53 >0.1 inhibit bone resorption 
  
Accession # Gene Name Fold Δ p-value Molecular Function 
AF153440 BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) 0.53 >0.05 antagonist to BMPs; involved in TGF-beta signaling pathway 
NM_011199 parathyroid hormone receptor1 0.54 >0.1 transmembrane receptor activity 
NM_009627 adrenomedullin 0.57 >0.1 neuropeptide hormone activity 
AI385532 thrombospondin 1 0.59 >0.1 involved in cell attachment 
BC014690 transforming growth factor, beta 3 0.59 <0.05 growth factor and cytokine activity 
NM_011580 thrombospondin 1 0.59 >0.1 cell attachment 
NM_007743 procollagen, type I, alpha 2 0.62 >0.1 the major constituent of bone matrix 
BG248060 bone morphogenetic protein 1 0.62 >0.1 metalloendopeptidase activity 
NM_007737 procollagen, type V, alpha 2 0.68 >0.1 present where there is collagen type I 
AF053954 cbfa1/runx2 (osf2) 0.69 >0.05 essential transcription factor for osteoblast differentiation and bone formation 
BB730912 interleukin 13 receptor, alpha 1 0.69 >0.1 inhibit bone resorption 
NM_020273 glucocorticoid modulatory element binding protein 1 0.70 >0.05 transcription factor activity 
S80963 interleukin 13 receptor, alpha 1 0.72 >0.1 inhibit bone resorption 
NM_019444 RAMP2 0.73 >0.1 calcitonin signal transducer activity 
NM_008216 hyaluronan synthase 2 0.74 <0.05 with versican-like protein works to captures space destined to become bone 
NM_007833 decorin 0.76 <0.025 binds to collagen and may regulate fibril diameter 
NM_007431 alkaline phosphatase 2, liver 0.82 <0.05 essential for hydroxyapatite formation and matrix mineralization 
BB082407 hyaluronan and proteoglycan link protein 4 1.22 >0.05 present in articular cartilage 
BM251152 chondroitin sulfate proteoglycan 2 1.23 >0.05 present in cartilage 
NM_009758 bone morphogenetic protein recepto, type 1A 1.37 >0.1 TGF-β and BMP receptor 
BG092290 insulin-like growth factor 2 receptor 1.43 <0.025 signal transduction and hormone activity 
NM_007802 cathepsin K 1.43 >0.1 may regulate elastic fiber formation (calcium ion binding activity) 
NM_020275 tumor necrosis factor receptor superfamily, member 10b 1.43 <0.05 growth factor and cytokine activity 
NM_008965 prostaglandin E receptor 4 1.45 >0.1 G-protein coupled receptor_activity 
BG069059 leucine rich repeat (in FLII) interacting protein 1 1.52 >0.05 leucine rich repeats involved in bone mineralization 
NM_010554 interleukin 1α 1.58 <0.05 potent stimulators of bone resorption 
NM_011361 serum/glucocorticoid regulated kinase 1.65 >0.05 transferase activity, transferring phosphorus-containing groups 
M94967 prostaglandin-endoperoxide synthase 2 2.05 >0.05 prostaglandins important in fluid shear over bone cells 
BM935811 integrin α6 2.47 <0.05 cell adhesion molecule 
AK003744 cystatin E/M 3.45 <0.05 antagonist to cathepsin family 
NM_011111 serine (or cysteine) proteinase inhibitor, clade B, member 2 7.14 >0.05 may be involved in osteoclast function with MMPs and cathepsins 
X75557 proliferin 14.4 >0.05 involved in cell adhesion; may regulate cathepsin L; involved in cell proliferation 
* Fold=simulated microgravity expression/static expression 
 Table 3 A list of statistically significant common genes sensitive to simulated microgravity in 2T3 cells using both RPM and 
RWV.  Sorted based on typical biological process (p<0.05).   
Accession # Gene Name *Fold Δ RWV 
*Fold Δ 
RPM Molecular Function 
Cell Adhesion     
NM_012050 osteomodulin  0.10 0.18 aka osteoadherin, may mediate cell attachment 
NM_007729 procollagen, type XI, alpha 1  0.37 0.29 extracellular matrix structural constituent 
NM_012043 immunoglobulin superfamily containing leucine rich repeat  0.18 0.42 involved in cell attachment 
AK004179 platelet-derived growth factor receptor-like  0.45 0.52 involved in cell attachment and possibly cell proliferation 
Cell Cycle     
NM_011817 growth arrest and DNA damage inducible, gamma  0.40 0.49 structural constituent of ribosome 
Development     
NM_009144 secreted frizzled-related sequence protein 2  0.43 0.41 transmembrane receptor and signal transduction activity 
Regulation of 
Cell Growth     
NM_030127 serine protease  0.74 0.22 serine-type endopeptidase activity 
NM_008760 osteoglycin  0.23 0.38 growth factor activity 
Protein 
Biosynthesis     
NM_026631 nucleolar protein family A, member 2  1.69 2.04 RNA binding; structural constituent of ribosome 
Transport     
AK018504 ras association (RalGDS/AF-6) domain family 2  0.27 0.43 protein binding 
Cell 
Differentiation     
NM_025711 asporin  0.15 0.28 porin activity; cartilage extracellular protein 
Metabolism     
NM_007934 glutamyl aminopeptidase  0.40 0.35 aminopeptidase activity 
Skeletal 
Development     
NM_054077 proline arginine rich end leucine rich repeat  0.43 0.45 extracellular matrix structural constituent 
Unknown     
NM_021355 fibromodulin 0.45 0.45 unknown 
* Fold=simulated microgravity expression/static expression 
 Table 4 Comparison of gene expression changes among RWV, RPM, and mechanical load microarrays.  Sorted by biological 
process.   
Accession # Gene Name Fold Δ RWV 
p-value 
RWV 
Fold Δ 
RPM 
p-value 
RPM 
Fold Δ 
in vivo 
p-value 
in vivo Molecular Function 
Cell Growth & 
Differentiation         
AK014259 osteoglycin 0.22 p<0.05 0.38 p<0.005 2.47 p<0.005 binds to TGF-Beta 
NM_008409 integral membrane protein 2A 0.31 p>0.1 0.53 p<0.05 2.85 p<0.005 marker gene of osteoblastic cells in bone formation 
NM_007792 cysteine and glycine-rich protein 2 0.65 p<0.05 0.68 p>0.1 4.12 p<0.0025 zinc ion binding 
AK011346 pleiotrophin 0.43 p>0.1 0.36 p<0.05 4.29 p<0.0025 involved in bone mineralization; growth factor binding 
Cell Adhesion         
NM_015734 procollagen, type V, alpha 1 0.56 p>0.05 0.65 p>0.1 1.97 p<0.0025 present in cartilage ECM 
NM_007739 procollagen, type VIII, alpha 1 0.57 p>0.05 0.68 p>0.1 2.56 p<0.0025 present in cartilage ECM 
Cell Death         
NM_008086 growth arrest specific 1 0.59 p>0.1 0.53 p<0.01 2.26 p<0.0025 protein binding 
Proteolysis         
NM_008788 procollagen C-proteinase enhancer protein 0.56 p<0.01 0.52 p<0.05 2.15 p<0.005 nucleic acid binding 
NM_011175 legumain 0.64 p>0.1 0.66 p>0.05 3.25 p<0.005 cysteine-type endopeptidase activity 
Signal 
Transduction         
NM_008809 platelet derived growth factor receptor, beta polypeptide 0.74 p>0.1 0.61 p>0.05 1.97 p<0.01 
protein serine/threonine kinase 
activity 
NM_009037 reticulocalbin 0.69 p<0.05 0.85 p>0.1 2.31 p<0.005 calcium ion binding 
Transcription 
regulation         
NM_010351 goosecoid 0.58 p>0.1 0.68 p>0.1 2.3 p<0.005 DNA binding 
NM_019791 melanoma antigen, family D, 1 0.54 p>0.1 0.55 p<0.005 2.33 p<0.0025 transcription coactivator activity 
Cytoskeletal 
Movement         
NM_007392 actin, alpha 2, smooth muscle, aorta 0.64 p>0.1 0.85 p>0.1 1.97 p<0.0025 structural constituent of cytoskeleton 
Other         
NM_009128 stearoyl-coenzyme A desaturase 2 0.4 p>0.1 0.35 p<0.0025 2.56 p<0.0025 iron ion binding 
AK004179  platelet-derived growth factor receptor-like 0.45 p<0.005 0.52 p<0.05 2.18 p<0.005 receptor activity 
 
  
 Table 5 Primers and LightCycler conditions used for Real-Time PCR  
GeneBank 
Accession No. Gene Primers (5’-3’) bp 
LightCycler 
Conditions Ref. 
NM_009820 Runx2 Fw GACAGAAGCTTGATGACTCTAAACC 171 7 sec;  62ºC (17) 
  Rv TCTGTAATCTGACTCTGTCCTTGT  9 sec; 72ºC  
NM_007554 BMP4 Fw CTGCGGGACTTCGAGGCGACACTTCT 150 7 sec; 65ºC (47) 
  Rv TCTTCCTCCTCCTCCTCCCCAGACTG  7 sec; 72ºC  
NM_011199 PthR1 Fw GCACACAGCAGCCAACATAA 531 7 sec at 63ºC (51) 
  Rv CGCAGCCTAAACGACAGGAA  22 sec at 72ºC  
NM_012050 Omd Fw GACGGGCTGGTGAATGTGACTATGCTTGA 147 7 sec; 63ºC (20) 
  Rv CCAAGGGGCATTGATTCTAATCTGTTATT  10 sec; 72ºC  
 
 
